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Abstract
Background: Modulation of the immune system is one of the most plausible mechanisms underlying the
beneficial effects of probiotic bacteria on human health. Presently, the specific probiotic cell products responsible
for immunomodulation are largely unknown. In this study, the genetic and phenotypic diversity of strains of the
Lactobacillus plantarum species were investigated to identify genes of L. plantarum with the potential to influence
the amounts of cytokines interleukin 10 (IL-10) and IL-12 and the ratio of IL-10/IL-12 produced by peripheral blood
mononuclear cells (PBMCs).
Results: A total of 42 Lactobacillus plantarum strains isolated from diverse environmental and human sources were
evaluated for their capacity to stimulate cytokine production in PBMCs. The L. plantarum strains induced the
secretion of the anti-inflammatory cytokine IL-10 over an average 14-fold range and secretion of the pro-
inflammatory cytokine IL-12 over an average 16-fold range. Comparisons of the strain-specific cytokine responses of
PBMCs to comparative genome hybridization profiles obtained with L. plantarum WCFS1 DNA microarrays (also
termed gene-trait matching) resulted in the identification of 6 candidate genetic loci with immunomodulatory
capacities. These loci included genes encoding an N-acetyl-glucosamine/galactosamine phosphotransferase system,
the LamBDCA quorum sensing system, and components of the plantaricin (bacteriocin) biosynthesis and transport
pathway. Deletion of these genes in L. plantarum WCFS1 resulted in growth phase-dependent changes in the
PBMC IL-10 and IL-12 cytokine profiles compared with wild-type cells.
Conclusions: The altered PBMC cytokine profiles obtained with the L. plantarum WCFS1 mutants were in good
agreement with the predictions made by gene-trait matching for the 42 L. plantarum strains. This study therefore
resulted in the identification of genes present in certain strains of L. plantarum which might be responsible for the
stimulation of anti- or pro-inflammatory immune responses in the gut.
Background
Metagenomics and host-microbe molecular interaction
studies are rapidly expanding our understanding of the
indigenous gut microbiota and the contributions of
microbes to human health [1,2]. These efforts are com-
plementary to the numerous reports describing health
benefits associated with the ingestion of probiotic bac-
teria [3,4]. Probiotics are living microorganisms which
confer health effects on the host when administered in
sufficient amounts [5]. Strains of Lactobacillus and Bifi-
dobacterium are the most commonly applied probiotics
in food products. Members of these genera are residents
of the human intestine and have a long history of safe
use in foods and beverages. Health benefits conferred by
probiotics can be specific to the gastrointestinal tract
(e.g. protection against intestinal inflammation or enteric
pathogens) or occur at peripheral mucosal sites in the
human body (e.g. prevention of allergy or dermatitis) [6].
There is substantial evidence that an important
mechanism by which probiotics provide health benefits
is through modulation of immune functions [7-11]. Dif-
ferences among probiotic strains to stimulate immune
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cells towards pro- and anti-inflammatory responses have
been shown in studies measuring cytokine production
in vitro [7-11]. These comparisons have resulted in the
identification of strains inducing similar responses
in vivo. For example, ratios of IL-10 to IL-12 produced
by Peripheral Blood Mononuclear Cells (PBMCs) in
response to different probiotics in vitro were correlated
to their protective capacity in a mouse model of colitis
[10]. Similarly, recent studies on the mechanisms of pro-
biotics highlight their effects on epithelial barrier func-
tion via Toll-like receptor 2 signaling and the generation
of regulatory dendritic cells and regulatory CD4+Foxp3+
T cells in peripheral tissues [12,13]. The latter mechan-
ism is linked to the administration of a collection of five
strains which induced a high IL-10/IL-12 ratio in co-
culture with immune cells [12]. Administration of these
strains was shown to have a therapeutic effect in experi-
mental mouse models of inflammatory bowel disease,
atopic dermatitis, and rheumatoid arthritis and was
associated with enrichment of CD4(+)Foxp3(+) Tregs in
the inflamed regions [12].
The cell products of probiotics that are responsible for
modulation of cytokine induction are largely not known
but might involve modifications of some of the known
Microbe Associated Molecular Patterns (MAMPs) such
lipoteichoic acids (LTA) [14-16] and (lipo)proteins loca-
lized on the bacterial cell surface [17] which interact with
Toll-like receptors. Additionally cell-surface associated
bacterial glycosylated proteins or exopolysaccharides [18]
may interact with other host pattern recognition recep-
tors including the C-type lectins and scavenger receptors
found on antigen presenting cells [19]. These extracellu-
lar and secreted products produced by probiotic cells are
the likely targets for strain-dependent interactions with
host cells and have been the focus of several recent
reviews [6,20,21].
Certain strains of Lactobacillus plantarum are mar-
keted as probiotics and reported to confer various health
effects including immunomodulation [22]. The genome
sequence of L. plantarum strain WCFS1 is known [23]
and extensive bioinformatics tools [24,25], molecular
models [26], and a database of genome hybridization
profiles [27,28] are available for this organism. It is a
single colony isolate of strain NCIMB8826, which was
shown to survive gastrointestinal passage after oral
administration to healthy volunteers [29]. Global gene
expression profiling of L. plantarum WCFS1 in the
intestinal contents of the human gut and convention-
ally-raised and germ-free mice has shown that this
organism adapts for growth in vivo by modification of
its cell-surface composition and metabolism in a diet-
dependent manner [30-34]. Human duodenal transcrip-
tional response profiles have also been obtained in
response to ingestion of L. plantarum WCFS1 [35,36].
Notably, exponential phase and stationary phase
L. plantarum WCFS1 cells elicited distinct human duo-
denal transcript profiles which appeared to mainly
result from differential modulation of canonical NF-b-
dependent signaling pathways associated with immune
tolerance [35].
The aim of the present study was to identify genes
involved in immunomodulation by L. plantarum WCFS1.
The IL-10 and IL-12 cytokine levels elicited by peripheral
blood mononuclear cells (PBMCs) upon stimulation with
L. plantarum WCFS1 and 41 other Lactobacillus plan-
tarum strains were determined. We compared the IL-10
and IL-12 stimulating phenotypes of each strain to its
genome composition determined by comparative genome
hybridization (CGH) to identify candidate L. plantarum
genes with the capacity to affect cytokine production in
PBMCs. The immunomodulatory potential of these gene
products was confirmed for L. plantarum WCFS1 gene
deletion mutants and found to be dependent on the
growth-phase of the L. plantarum cultures.
Results
Immunomodulation of PBMCs is a variable
phenotype in L. plantarum
A total of 42 L. plantarum strains from distinct (fermen-
ted) food, environmental, and gastrointestinal sources
(Table 1 and [27,28]) were investigated for their capacities
to stimulate PBMCs to produce the cytokines IL-10 and
IL-12. Comparisons of cytokine amounts induced among
different donors in response to the L. plantarum strains
showed that the L. plantarum cultures induced a similar
range of IL-10 but up to 10-fold different levels of IL-12
(Figure 1). This result is agreement with previous studies
showing that PBMCs respond differently depending on
the donor from which the cells were isolated [37]. How-
ever, the capacity of individual L. plantarum strains to
induce cytokines production in PBMCs was similar among
the different donors relative to the other strains tested. For
example, L. plantarum KOG18 consistently induced the
highest amounts of IL-12 whereas strain CIP104448
induced the highest ratios of IL-10 to IL-12. Collectively,
the 42 L. plantarum strains induced, on average, IL-10
and IL-12 in PBMCs over a 14- and 16 - fold range,
respectively, and IL-10/IL-12 ratios over a 13.5 - fold
range (Figure 1). Strain WCFS1 induced relatively low
IL-10 amounts (between 440 and 780 pg/ml), moderate
amounts of IL-12 (between 20 and 260 pg/ml), and conse-
quently a moderate to low IL-10/IL-12 ratio (bottom quar-
tiles) compared with the other strains (Figure 1).
Identification of candidate genes involved
in immunomodulation
To identify candidate L. plantarum genes involved in
the modulation of the immune response, Random Forest
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models [38] were used to compare L. plantarum CGH
profiles with the relative amounts of IL-10 and IL-12
and IL-10/IL-12 ratios induced by the strains in co-
culture with PBMCs (Figure 1). PBMCs from different
donors incubated with replicate L. plantarum cultures
were used for these models to take into account the
levels of variation in cytokine production. Comparisons
of L. plantarum strain genotype to the IL-10-stimulating
capacities resulted in the identification of 6 different
chromosomal loci and a total of 13 genes that might
influence IL-10 production (Table 2). In comparison,
concise correlations between L. plantarum CGH profiles
and IL-12 amounts were not found. One of the genes
correlated with IL-10 amounts was L. plantarum
WCFS1 lp_1953. L. plantarum strains harboring this
gene stimulated the production of IL-10 in 1.6-fold
higher amounts, on average, compared to L. plantarum
strains for which this gene was absent. Lp_1953 encodes
a hypothetical intracellular protein of unknown function
[25]. The remaining five genes with putative roles in
IL-10 modulation comprise a putative 5 gene operon
(lp_2647 to lp_2651) encoding Pts19ADCBR, an
N-acetyl-galactosamine/glucosamine phosphotransferase
system (PTS). Strains harboring these genes were asso-
ciated with induction of lower amounts of IL-10 by
PBMCs.
Comparisons between L. plantarum strain-specific
CGH profiles and IL-10/IL-12 ratios from PBMCs
resulted in the identification of four L. plantarum
WCFS1 loci which correlated with IL-10/IL-12 values
(Table 2). L. plantarum WCFS1 plnEFI and plnG
(lp_419-423) and lamB (lp_3582) were most commonly
present in strains stimulating low IL-10/IL-12 ratios.
These genes are under the control of the auto-inducing
peptide (AIP)-based quorum sensing (QS) two-
component regulatory systems (QS-TCSs) found in
L. plantarum [39,40]. The genes plnEFI and plnG
encode two bacteriocin peptides, a bacteriocin immunity
protein, and an ATP - Binding Cassette (ABC) transpor-
ter [23,41]. The lamB is the first gene in the L. plan-
tarum lamBDCA operon and shows 30% amino acid
identity to the S. aureus AgrD-processing protein AgrB
required for AIP modification and export [39]. The
other L. plantarum genes associated with specific IL-10/
IL-12 ratios are lp_2460 and lp_2480 coding for proph-
age R-Lp3 remnant proteins P2b protein 21 and 1,
respectively [23]. These genes are conserved among
L. plantarum strains stimulating high IL-10/IL-12 ratios
in PBMCs. The functions of prophage R-Lp3 and other
complete prophages in L. plantarum WCFS1 genome
are not known [42]. Because the different prophages
found in L. plantarum WCFS1 share high levels of
sequence homology and potential functional redundancy
[42], these genes were not examined further.
Table 1 L. plantarum strains selected for genotyping and
screening for immunomodulatory capacity
Strain Strain IDa Isolation source Geographical
origin
WCFS1 NIZO1836 Human saliva n.a.
LP80 NIZO2263 Silage n.a.
Lp95 NIZO2814 Wine red grapes Italy
CIP102359 CIP102359 Human spinal fluid France
ATCC8014 NIZO2726 Maize ensilage n.a.
LD3 NIZO2891 Radish pickled Vietnam
CHEO3 NIZO2457 Pork pickled sour
sausage
Vietnam
LD2 NIZO2535 Orange fermented Vietnam
BLL(EI31) NIZO2830 n.a. Not known
CIP104452 NIZO2259 Human tooth abscess France
CECT221
(24Ab04)
NIZO2831 Grass silage United States
LM3 NIZO2262 Silage n.a.
NCTH27 NIZO2494 Pork pickled sour
sausage
Vietnam
NCDO1193 NCDO1193 Vegetables n.a.
LMG9208 NIZO2806 Sauerkraut United Kingdom
ATCC14917 NIZO2896 Cabbage pickled Denmark
NOS140 NIZO2741 Cabbage kimchi Japan
299 NIZO1837 Human colon United Kingdom
N58 NIZO2855 Pork pickled sour
sausage
Vietnam
X17 NIZO2877 Hot dog Vietnam
299v/DSM9843 NIZO2260 Human intestine United Kingdom
MLC43 NIZO2029 Raw cheese with
rennet
Italy
LAC7 NIZO2889 Banana fermented Vietnam
LP85-2 NIZO2264 Silage France
NCTH19-1 NIZO2484 Pork pickled sour
sausage
Vietnam
NCTH19-2 NIZO2485 Pork pickled sour
sausage
Vietnam
NC8 NIZO2261 Grass silage Sweden
KOG24 NIZO2802 Cheese Japan
KOG18 NIZO2801 Turnip pickled Japan
LMG18021 NIZO3400 Milk Senegal
Q2 NIZO2753 Sourdough fermented Italy
SF2A35B NIZO1839 Sour cassava South America
CIP104451 NIZO2258 Human urine France
CIP104450 NIZO2257 Human stool France
CIP104448 CIP104448 Human stool France
DKO22 NIZO2897 Sour cassava Nigeria
H14 NIZO2766 Sourdough fermented Italy
H4 NIZO2757 Sourdough fermented Italy
CECT4645 NIZO2776 Cheese n.a.
CIP104441 NIZO2256 Human stool France
CIP104440 NIZO1838 Human stool France
NCIMB12120 NIZO1840 Cereal fermented (Ogi) Nigeria
n.a. not available.
a See references [27,28] for comparative genome hybridization analyses of
these strains.
van Hemert et al. BMC Microbiology 2010, 10:293
http://www.biomedcentral.com/1471-2180/10/293
Page 3 of 13
600
700
60
702500
A B
400
500
(p
g/
m
l) 
do
no
r A
40
50
g/
m
l) 
do
no
rs
 B
 a
nd
 C
1500
2000
do
no
rs
 A
, B
 a
nd
 C
100
200
300
IL
-1
2 
10
20
30
IL
-1
2 
(p
g
500
1000
IL
-1
0 
(p
g/
m
l) 
0
0 1 2 3 4
0
35
40
100
120 WCFS1 ATCC14917
MLC43 CHE03
NCTH19-1 NCTH19-2
NCTH27 LD2 (2)
0
0 1 2 3 4 A-1 B-2 C-1&2A-1 B-2 C-1&2
C
20
25
30
0/
IL
-1
2 
do
no
r A
60
80
L-
12
 d
on
or
 B
 a
nd
 C
N0S1140 Q2
H4 H14
CECT4645 KOG18
KOG24 LMG9208
Lp95 B2830
B2831 B58
X17 LAC7
LD3 DK022
5
10
15IL
-1
0
20
40 IL
-1
0/
IL 299 CIP104440
SF2A35B NCIMB12120
CIP104441 CIP104450
CIP104451 CIP104452
299v NC8
LM3 LP80
LP85-2 ATCC8014(2)
NCDO1193 CIP102359
0
0 1 2 3 4
0
CIP104448 LMG18021
PBS LPSA-1 B-2 C-1&2
Figure 1 Cytokine secretion by PBMCs after 24 h co-culture with L. plantarum strains. IL-10 (A) and IL-12 (B) production and the IL-10/IL-12
ratio (C) by peripheral blood mononuclear cells (PBMCs) derived from blood of 3 different healthy donors after stimulation with 42 different
L. plantarum strains harvested in stationary-phase. The L. plantarum strains grown and prepared on separate days constitute set 1 and set 2.
PBMCs isolated from donor A were inoculated with L. plantarum culture set 1 (A-1) and PBMCs from donor B were inoculated with the
L. plantarum replicate set 2 (B-2). PBMCs from Donor C received both sets of cultures and the mean of the IL-10 and IL-12 amounts induced
by these cultures is shown. Each symbol represents a different L. plantarum strain or the PBS or LPS controls.
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Verification of the roles of the candidate genes
in immunomodulation
To validate the influence of the candidate L. plantarum
genes on PBMC cytokine responses, lp_1953, pts19AD-
CBR, plnEFI, and plnG deletion mutants were con-
structed for L. plantarum WCFS1. A previously
constructed L. plantarum WCFS1 lamA (lp_3580)lamR
(lp_3087) double mutant was used to examine the
potential roles of the lamBCDA QS-TCS on PBMCs.
This strain was selected because lamA and lamR
encode the response regulators of the 2 TCS (lamBCDA
and lamKR) regulating the expression of the LamD AIP
in L. plantarum WCFS1 [40]. In the ΔlamA ΔlamR
mutant, expression levels of lamB and the other genes
in this operon were at 5% of the levels found in wild-
type cells [40].
Wild-type and mutant L. plantarum WCFS1 cells har-
vested in the stationary- and exponential phases of
growth were examined for their capacity to stimulate
IL-10 and IL-12 in PBMCs. Overall, among the donors
examined, IL-10 and IL-12 were produced in response
to L. plantarum at levels between 500 to 4500 pg/ml
and 3 to 68 pg/ml, respectively (shown as log2 values in
Figure 2 and 3). Notably, exponential cultures of wild-
type L. plantarum WCFS1 and most mutant strains sti-
mulated PBMCs to secrete higher amounts of IL-10 and
IL-12 than stationary-phase cells (Figure 2 and 3).
L. plantarum strains harboring the plnEFI, plnG or
lamB loci were associated with the stimulation of lower
IL-10/IL-12 ratios by L. plantarum in the PBMC assay
(Table 2). In agreement with the gene-trait correlations,
the plnEFI, plnG, and lamA lamR deletion mutants of
strain WCFS1 induced higher IL-10/IL-12 ratios than
the wild-type strain (Figure 4 and Table 3). However,
the effects of the plnEFI deletion on cytokine induction
in different donors was not highly significant compared
to wild-type L. plantarum when the p value was
adjusted for multiple hypothesis testing (adjusted (adj.)
p value = 0.071) (Figure 4 and Table 3). Mutants defi-
cient in the ABC- transporter plnG induced significantly
higher cytokine ratios compared with L. plantarum
Table 2 L. plantarum genes with putative roles in modulating PBMC cytokine production.
Genes(s) Gene numbera Product Percent of strains
with the gene(s)b
Gene-dependent contribution to
cytokine stimulationc
lp_1953 lp_1953 Hypothetical protein 48 IL-10 1.6-fold ↑
pts19ADCBR lp_2647-2651 N-galactosamine PTS, EIIADCB and
transcription regulator, GntR family
33 IL-10 1.7-fold ↓
plnEFI lp_0419-0422 Immunity protein PlnI 81-85 IL-10/IL-12 1.7-fold ↓
Bacteriocin-like peptide PlnF
Bacteriocin-like peptide PlnE
plnG lp_0423 ABC transporter 88 IL-10/IL-12 1.8-fold ↓
lamB lp_3582 Accessory gene regulator protein 43 IL-10/IL-12 1.3-fold ↓
prophage P2b 1 & 21 lp_2460 Prophage P2b protein 21 38 IL-10/IL-12 1.5-fold ↑
lp_2480 Prophage P2b protein 1, integrase
a Gene number on the L. plantarum WCFS1 chromosome [23].
b Percentage of L. plantarum strains containing the gene according to CGH [27,28].
c Gene-trait matching importance measures (in parentheses) and predicted effects of the gene(s) on the variable and average magnitude and direction (higher or
lower) of IL-10 and IL-10/IL-12 amounts.
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Figure 2 Boxplots of IL-10 amounts produced by PBMCs in
response to L. plantarum wild-type and mutant cells. 2Log
transformed IL-10 amounts induced by exponential and stationary
phase L. plantarum cells are shown. The dots indicate the median
value, the boxes indicate first and third quartile, and the whiskers
extend to outlying data points for a total of 12 measurements
(3 PBMC donors were measured using 4 replicate cultures of each
L. plantarum strain).
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wild-type cells (Figure 4 and Table 3). These differences
were observed only for wild-type and mutant cells har-
vested during exponential phase growth (adj. p value =
0.005). Immunomodulation of the ΔlamA ΔlamR
mutant was also substantially different compared to
wild-type L. plantarum WCFS1. The ΔlamA ΔlamR
mutant induced significantly higher IL-10/IL-12 ratios
(adj. p value = 0.016) and IL-12 (adj. p value < 0.001)
and IL-10 (adj. p value < 0.001) amounts in PBMCs
(Table 3). These effects were partially dependent on the
growth-phase of the L. plantarum cells. IL-10/IL-12
ratios and IL-10 amounts induced by wild-type and
mutant cells were significantly different when exponen-
tial phase cultures were used in the PBMC assay,
whereas IL-10 and IL-12 amounts also differed when
stationary-phase cells were examined (Figure 2, 3, 4 and
Table 3).
In agreement with the gene trait matching correla-
tions, the Δpst19ADCBR mutant induced significantly
higher amounts of IL-10 than wild-type L. plantarum
(adj. p value = 0.031) (Figure 2 and Table 3). Similarly,
the IL-10/IL-12 ratio was significantly higher (p < 0.001)
upon stimulation with L. plantarum Δpst19ADCBR
compared with the parental strain (Figure 4 and Table
3). L. plantarum strains harboring lp_1953 were also
predicted to induce higher IL-10 production levels com-
pared with strains lacking this gene. However, the
L. plantarum lp_1953 deletion mutant stimulated
equivalent amounts of IL-10 and somewhat higher
IL-10/IL -12 ratios (adj. p value = 0.024) relative to
wild-type L. plantarum WCFS1 (Figure 4 and Table 3).
Although the lp_1953 mutant induces a modest, yet sig-
nificantly different, IL-10/IL-12 response relative to the
parental strain, these results are not in agreement with
the immunomodulatory effects predicted for this gene.
In summary, of the 5 mutants tested here, three
(ΔlamA ΔlamR, Δpst19ADCBR, and ΔplnG) significantly
affected the immune response of PBMCs in different
donors according to the phenotypes predicted from the
gene-trait matching data (Table 2). The plnEFI mutant
also affected the immune response in the predicted
manner but this was not significant considering the
adjusted p value. The ΔlamA ΔlamR mutant conferred
the largest differences on the induction of IL-10 and IL-
12 and the IL-10/IL-12 ratio by L. plantarum (Table 3).
Discussion
This study demonstrated the diverse capacities of
L. plantarum strains to stimulate cytokine production in
human PBMCs and confirmed the contributions of
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Figure 3 Boxplots of IL-12 amounts produced by PBMCs in
response to L. plantarum wild-type and mutant cells. 2Log
transformed IL-12 amounts induced by exponential and stationary
phase L. plantarum cells are shown. The dots indicate the median
value, the boxes indicate first and third quartile, and the whiskers
extend to outlying data points for a total of 12 measurements
(3 PBMC donors were measured using 4 replicate cultures of each
L. plantarum strain).
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Figure 4 Boxplots of IL-10/IL-12 amounts produced by PBMCs
in response to L. plantarum wild-type and mutant cells. 2Log
transformed IL-10/IL -12 ratios induced by exponential and
stationary phase L. plantarum cells are shown. The dots indicate the
median value, the boxes indicate first and third quartile, and the
whiskers extend to outlying data points for a total of 12
measurements (3 PBMC donors were measured using 4 replicate
cultures of each L. plantarum strain).
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specific L. plantarum genes to modulate these
responses. Forty-two L. plantarum strains induced
PBMCs to secrete IL-10 over an average 14-fold range.
This range was similar to IL-10 amounts stimulated by
7 Bifidobacterium longum strains [43] and the 10 to 15-
fold differences in cytokine amounts induced in PBMCs
by multiple Lactobacillus and Bifidobacterium species
[7-11]. Moreover, we found that variation in IL-10 and
IL-12 amounts and IL-10/IL-12 ratios induced by the
distinct L. plantarum strains was higher than reported
previously [44]. This result was probably due to the ana-
lysis of more strains in the present study (42 versus 3),
which were isolated from diverse environmental niches
encompassing a greater genetic and phenotypic diversity
of the L. plantarum species. Such strain-specific differ-
ences should therefore be taken into consideration when
selecting a probiotic Lactobacillus culture for health
conditions which are dependent on modulating immu-
nity such as in the prevention of allergy, eczema, or
inflammatory bowel disease.
To identify L. plantarum genes with roles in modu-
lating immune cell responses, L. plantarum genetic
diversity was correlated with strain-specific capacities
to induce cytokines in PBMCs. Genes with putative
contributions to the observed PBMC responses were
further investigated in L. plantarum WCFS1. A similar
gene-trait matching approach previously resulted in
the identification of a L. plantarum mannose-specific
adhesin (Msa) [45] and genes which modulate dendri-
tic cell responses [46]. Although the gene-trait matching
approach has been successful, it should be recognized
that only a subset of immunomodulatory cell compo-
nents produced by L. plantarum was likely identified
here. Firstly, the identified immunomodulatory genetic
loci were restricted to genes in the L. plantarum
WCFS1 reference strain genome. Secondly, genes with
high levels of sequence conservation such that they are
not distinguished by CGH (presence versus absence,
rather than minor sequence variations) might be
excluded from detection. For example, L. plantarum
highly conserved LTA biosynthesis and modification
genes known to have established effects on mammalian
immunity were not found in this biodiversity-based
gene-trait matching approach. Finally, genetic assess-
ments do not take into account strain-specific variations
in gene expression, translation, or post-translational
modification of proteins with immunomodulatory
effects.
Despite these limitations and the considerable varia-
tion in the production of cytokines by PBMCs from dif-
ferent donors, the present study demonstrated that
gene-trait matching is also suitable for the identification
of genes that affect cytokine levels in the mixture of
immune cells collectively termed PBMCs. The products
of AIP-based QS-TCSs and the N-acetyl-galactosamine/
glucosamine phosphotransferase system identified here
might constitute a new class of bacterial cell products
which are recognized by host receptors. The findings
are significant because these genes were identified using
intact cells which likely have multiple interactions with
immune cells such that single genes only confer incre-
mental effects.
L. plantarum WCFS1 lamB, a processing/export
protein of the AIP-based QS-TCS LamBDCA [47], was
correlated with immunomodulation of PBMCs. LamB, a
transmembrane protein, is under the control of two
response regulators lamA and lamR [40]. A L. plantarum
ΔlamA ΔlamR mutant investigated in this study was
Table 3 Relative differences in cytokine amounts between L. plantarum WCFS1 wild-type and deletion mutants.
IL-10c IL-12 IL-10/IL-12
Mutant
comparisona
Growth
phaseb value p-value
adj. p-
value value p-value
adj. p-
value value p-value
adj. p-
value
lp_1953 log 0.097 0.461 0.830 -0.041 0.775 0.825 0.138 0.161 0.803
stat 0.253 0.057 0.228 -0.043 0.761 0.825 0.296 0.003 0.024 *
pts19ADCBR log 0.164 0.216 0.647 0.106 0.458 0.825 0.058 0.556 0.923
stat 0.396 0.004 0.031 * -0.131 0.371 0.825 0.529 0.000 0.000 ***
plnEFI log 0.287 0.031 0.176 0.032 0.825 0.825 0.255 0.010 0.071
stat 0.344 0.010 0.071 0.174 0.225 0.825 0.170 0.084 0.507
plnG log 0.280 0.035 0.176 -0.070 0.625 0.825 0.350 0.000 0.005 **
stat -0.028 0.830 0.830 -0.146 0.307 0.825 0.118 0.230 0.921
lamA lamR log 0.511 0.000 0.001 *** 0.199 0.165 0.825 0.312 0.002 0.016 *
stat 1.331 0.000 0.000 *** 1.321 0.000 0.000 *** 0.009 0.923 0.923
a L. plantarum WCFS1 deletion mutant measured in the PBMC assay.
b Phase of growth from which L. plantarum cells were harvested (log = exponential phase; stat = stationary phase).
c The value is the average difference in 2Log cytokine amounts induced by wild-type L. plantarum and mutant cells harvested in the same phase of growth (log
or stat). A positive value indicates an increase in IL-10 levels produced by PBMCs in response to mutant L. plantarum compared to the wild-type cells.
Calculations of t-test p-values and adjusted (adj.) p-values are described in the text (Materials and Methods). * (0.01 < p < 0.05); ** (0.002 < p < 0.01); *** (p <
0.002) for the adj. p-values.
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found to induce PBMCs to secrete significantly higher
amounts of the cytokines IL-10 and IL-12. In a previous
report, global transcript profiling of the lamA lamR
deletion mutant showed that the lamBDCA system is
auto-regulated and controls the production of several
surface-associated proteins, stress-associated functions,
and surface polysaccharides [40]. Higher amounts of sur-
face polysaccharides produced by L. plantarum ΔlamA
ΔlamR decreased the biofilm-forming capacity of the
mutant strain [40]. Polysaccharides produced by some
Lactobacillus species are known for their immunomodu-
latory effects either by direct interactions with immune
cells or by shielding MAMPs on the bacterial cell surface
from detection by the immune system [18,48,49]. There-
fore the observed PBMC IL-10/IL-12 ratios for L. plan-
tarum might either be mediated directly through the
LamBDCA system and the cognate secreted peptide, or
indirectly through cell products (e.g., polysaccharides)
under the control of this regulatory system. The latter is
supported by the genetic similarities between LamBDCA
and the Staphylococcus aureus agr system, an AIP-based
QS-TCS which controls the evasion of innate host
defenses by S. aureus through the production of secreted
peptides and proteases [50].
The plantaricin biosynthesis pathway of L. plantarum
WCFS1 is also controlled by an AIP-based QS-TCS [47]
and genes required for plantaricin production and trans-
port contributed to L. plantarum effects on PBMCs.
Plantaricin is a bacteriocin composed of two small
secreted peptides (plnE and plnF) which destabilize the
integrity of the plasma membrane of susceptible cells
[51]. L. plantarum strains harboring plnEF and plnI
encoding a plantaricin immunity protein, and/or plnG
encoding a membrane bound ABC-transporter induced
PBMCs to secrete IL-10 and IL-12 in amounts that
yielded lower IL -10/IL-12 ratios (Table 2). Similarly,
wild-type L. plantarum WCFS1 conferred lower IL-10/
IL-12 ratios compared to the plnEFI and plnG deletion
mutants, although this was significant only for the plnG
mutant (p = 0.005) and not the mutant lacking plnEFI
(p = 0.071). The identification of the AIP plantaricin is
intriguing because human antimicrobial peptides such
as defensins secreted in the gut are known to modulate
immune responses [52,53] and suggest that antimicro-
bial peptides of bacterial origin might have similar capa-
cities. These findings are also compatible with a recent
study showing that plantaracins can modulate dendritic
cell responses [46]. Moreover, several independent stu-
dies showed that L. plantarum WCFS1 genes involved
plantaricin biosynthesis and activity, including plnI and
plnF, are induced in the mouse gut [30-32], thereby
indicating that plantaricin production is active in the
intestine where it might come into contact with mucosal
immune cells.
Another of the confirmed genes with immunomodula-
tory capacities was the pts19ADCBR locus coding for a
cell membrane-associated N-acetyl-galactosamine/gluco-
samine phosphotransferase system. The relevance of the
pts19ADCBR genes in adaptation to the intestinal ecosys-
tem was also demonstrated by their higher expression
levels in the intestine of conventionally-raised and germ-
free mice [31,32]. Moreover, in Lactobacillus johnsonii, a
putative mannose phosphotransferase gene locus with
43% amino acid identity to the L. plantarum WCFS1
pts19ADCBR cluster was found to be important for long
term persistence in vivo [54]. Although the regulatory
signals for expression of these genes are unknown,
immunomodulatory effects conferred by Pts19ADCBR
might influence the ability of L. plantarum to modify the
intestinal environment for survival in the gut.
Cytokine profiles of the lp_1953 deletion mutant were
not in agreement with the IL-10 stimulating capacity pre-
dicted for this gene by gene-trait matching. This result
exemplifies the need for mutation analysis to confirm
gene-trait predictions, which are likely to encompass
false-positive associations. A similar conclusion was
drawn during the identification of the L. plantarum Msa
gene [45]. Moreover, the product of lp_1953 is predicted
to be intracellular, which contrasts the predicted subcel-
lular location of all other genes examined here (secreted
or cell envelope associated) [24,25]. This finding supports
the notion that surface-localized proteins or components
are the most likely candidate-participants in host-
microbe interactions [49,55]. Thus far, the majority of
the known immunomodulating MAMPs known for lacto-
bacilli are extracellular or cell surface associated products
such as LTA, exopolysaccharides, and peptidoglycan,
although intracellular CpG-containing oligodeoxynucleo-
tides (ODNs) produced by some lactobacilli are able to
induce IL-10 production in immune cells [21,49]. These
MAMPs are recognized by specific Pattern Recognition
Receptors (PRRs) such as Toll-like receptors (TLRs) and
nucleotide oligomerization domain (NOD)-like receptors
[21]. To identify the mechanisms underlying the effects
of AIP-based QS-TCSs and the N-acetyl-galactosamine/
glucosamine phosphotransferase system on immune
cells, the cellular products encoded by the genes in these
pathways should be investigated to identify the specific
cell types among the PBMCs, which include lymphocytes,
monocytes and macrophages, that recognize these com-
pounds as well as the specific mechanisms leading to
altered cytokine production.
Comparisons of mutant and wild-type L. plantarum
WCFS1 cells included examination of the effects of cul-
ture growth phase on the stimulation of PBMCs. Expo-
nential- and stationary-phase L. plantarum WCFS1
cultures were evaluated because the growth phase of
probiotic cells was previously shown to influence the
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immune responses to probiotic bacteria in vitro [56-59]
and in vivo [35]. Using human PBMCs, we found signifi-
cant growth-phase dependent differences in the immu-
nomodulatory capacities of the wild-type and mutant
L. plantarum cultures. Collectively, the exponential-
phase L. plantarum WCFS1 cultures stimulated higher
absolute amounts of IL-10 and IL-12 and hence appear
to induce heighted immune responses by PBMCs com-
pared with stationary-phase cells. Notably, this result
was not due to extensive L. plantarum growth because
antibiotics were added to the PBMC growth medium to
prevent bacterial overgrowth which would generate arti-
facts from acidification of the medium causing PBMC
cell stress or death. Moreover, intact and lysed L. plan-
tarum strains cells collected from the exponential and
stationary phase of growth do not show striking differ-
ences in their TLR9 signaling activity and there was not
a clear trend among all strains tested (personal observa-
tion, M. Meijerink and J. M. Wells). Therefore the
higher amounts of cytokines induced by exponential
phase bacteria are unlikely to be caused by differential
cell lysis resulting in the release of intracellular CpG
DNA, a known MAMP recognized by TLR9.
Comparisons of wild-type and mutant L. plantarum
cultures also showed growth-phase dependent effects.
The IL-10 amounts and IL-10/IL-12 ratios induced by
the pts19ADCBR deletion mutant were significantly dif-
ferent from wild-type L. plantarum WCFS1 for only the
stationary-phase cultures. Stationary-phase cells of the
ΔlamA ΔlamR mutant also induced significantly higher
amounts of IL-10 and IL-12 in compared with L. plan-
tarum WCFS1 harvested at the same growth phase.
However, differences between IL-10/IL-12 ratios induced
by ΔlamA ΔlamR and wild-type cell differed only for
exponential phase cultures. This result might have been
partially due to the extensive alterations in expression of
L. plantarum ΔlamA ΔlamR in actively growing cultures
[39], such that differences in expression of lamBDCA
and lamKR regulated genes might have influenced the
ability of the exponential-phase L. plantarum cells to sti-
mulate different PBMC IL -10/IL -12 ratios. A similar
result was found for the comparisons of L. plantarum
plnG (and plnEFI), the other 2 TCS system examined,
although the specific growth-phase-dependent modifica-
tions of the plantaricin system on cytokine production in
PBMCs is not presently known.
Conclusions
The present study compared the genetic and phenotypic
diversity of L. plantarum WCFS1 to identify cell compo-
nents of this species with the capacity to modulate human
PBMC responses. We successfully identified several
L. plantarum WCFS1 genes that are associated with the
production of anti- and pro-inflammatory cytokines by
PBMCs and established that the immune response to
L. plantarum can be significantly altered by the deletion of
specific L. plantarum cell surface proteins. The increased
IL-10/IL-12 ratios of the L. plantarum mutants indicate
that these cultures would be more protective against
intestinal inflammation compared with wild-type cells.
These effects might be mediated by the down-regulation
of local inflammatory responses through various subsets of
T cells producing a collection anti-inflammatory cytokines.
As a result of this study, strain selection for protection
against intestinal inflammation might include screening
for strains lacking the LamB, PlnG, or Pts19 homologs or
by modifying culture growth conditions or food delivery
matrices to minimize the expression of these genes in vivo.
Such studies are required to distinguish between health
effects conferred by individual probiotic strains and to
develop methods to ensure that probiotic cells express
host-modulatory cell products at the appropriate level and
time in food products and the human gut.
Methods
Bacterial strains
Immune assays and genetic analysis was performed on a
total of 42 L. plantarum strains with distinct phenotypic
profiles [27,28] (Table 1). Comparative genome hybridi-
zation (CGH) of these strains was performed previously
[27,28]. For immunoprofiling, the L. plantarum strains
were grown at 37°C in Mann-Rogusa Sharpe (MRS)
broth (Merck, Darmstadt, Germany) until mid-exponen-
tial (optical density (OD) 600 nm = 1) phase or stationary
phase (24 h after the start of the culture, OD600 nm =
7.6 ± 1.1) [60]. The exponential and stationary phase
cells were washed twice in phosphate buffered saline
(PBS) at pH 7.4, suspended at 2 × 108 cells/ml in PBS
containing 20% glycerol, and stored at -80°C until co-cul-
turing with human immune cells. Quantification of the
exponential and stationary phase viable cells before and
after freezing showed no significant losses in cell viability
(data not shown). Colony forming units (CFUs) were
determined by plating serial dilutions of the cultures on
MRS agar (data not shown).
Peripheral blood mononuclear cells assay
This study was approved by Wageningen University
Ethical Committee and was performed according to the
principles of the Declaration of Helsinki. Peripheral
blood of healthy donors was from the Sanquin Blood
Bank, Nijmegen, The Netherlands. Before sample collec-
tion, a written informed consent was provided. Periph-
eral blood mononuclear cells (PBMCs) were separated
from the blood of healthy donors using Ficoll-Paque
Plus gradient centrifugation according to the manufac-
turer’s protocol (Amersham biosciences, Uppsala,
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Sweden). After centrifugation the mononuclear cells
were collected, washed in Iscove’s Modified Dulbecco’s
Medium (IMDM) + glutamax (Invitrogen, Breda, The
Netherlands) and adjusted to 1 × 106 cells/ml in IMDM +
glutamax supplemented with penicillin (100 U/ml) (Invi-
trogen), streptomycin (100 μg/ml) (Invitrogen), and 1%
human AB serum (Lonza, Basel, Switzerland). PBMCs (1 ×
106 cells/well) were seeded in 48-well tissue culture plates.
After an overnight rest at 37°C in 5% CO2, 5 μl aliquots of
thawed bacterial suspensions at 2 × 108 CFU/ml were
added to the PBMCs (L. plantarum: PBMC ratio of 1:1).
PBS (5 μl) and LPS (1 μg) served as negative (PBS) and
positive (LPS, TLR4 ligand) controls for the stimulation of
PBMCs. IL-10 was produced in sufficient amounts for
quantification in response to LPS but not to PBS.
Similarly, neither LPS nor the PBS buffer stimulated the
production of IL-12. To test the capacity of the 42 L. plan-
tarum strains to stimulate PBMC cytokine production,
PBMCs from 3 different donors were examined (donors
A, B, and C). For donors A and B, separate stationary-
phase cultures of each L. plantarum strain were used. For
donor C, both replicate cultures of each L. plantarum
strain were examined. In PBMC assays comparing
responses to L. plantarum WCFS1 wild-type and mutant
strains, PBMCs from 3 different donors were examined
using 4 independent replicate wild-type and mutant
L. plantarum cultures harvested during exponential-phase
and stationary-phase of growth.
Following 24 hr incubation at 37°C in 5% CO2, culture
supernatants were collected and stored at -20°C until
cytokine analysis. This time point was selected for analy-
sis because previous studies showed that IL-12 levels
remain unaltered after 4 days of L. plantarum incuba-
tion with PBMCs. Although IL-10 was shown to
increase 2- fold after 4 days of co-incubation with
L. plantarum, sufficient cytokine amounts were pro-
duced after 24 h to permit flow cytometric measure-
ments [61]. No viable bacteria could be cultured and
medium acidification was not observed after incubation
of L. plantarum strains with the PBMCs for 24 h (data
not shown). Cytokines were measured using a FACS
CantoII flow cytometer (BD Biosciences, Franklin Lakes,
New Jersey) and BD Cytometric Bead Array Flexsets
(BD Biosciences) for interleukin (IL)-10 and IL-12p70
(henceforth referred to as IL-12) according to the manu-
facturer’s recommendations. Detection limits were 0.13
and 0.6 pg/ml for IL-10 and IL-12 respectively. Concen-
trations of analytes were calculated with the use of
known standards and plotting the sample values against
a standard curve in the BD Biosciences FCAP software.
Donor-specific variation in cytokine production capaci-
ties was taken into account by dividing the cytokine
amounts induced by individual L. plantarum strains
against average cytokine quantities induced by all
L. plantarum strains for the same donor. These values
were then compared to amounts induced by L. plan-
tarum WCFS1 and used for gene-trait matching.
Identification of candidate genes involved in cytokine
secretion by gene-trait matching
L. plantarum genes with potential roles in modulating
of PBMC cytokine production were identified by
in silico matching using genotype information refer-
enced from the L. plantarum WCFS1 genome (also
termed gene-trait matching) [45]. Individual L. plan-
tarum WCFS1 gene presence or absence scores for the
42 strains were used as putative predictor variables for
PBMC induced IL-10, IL-12 and IL-10/IL-12 amounts
by regression using the Random Forest algorithm [38].
The “RandomForest” package for R [62] was used with
standard parameter settings. L. plantarum WCFS1
genes with the highest variable importance measures by
the Random Forest method were selected for deletion
analysis.
Construction of L. plantarum WCFS1 gene
deletion mutants
A previously described L. plantarum ΔlamA ΔlamR
mutant was used in this study [40]. Construction of
L. plantarum lp_1953, lp_2647-2651, lp_0419-0422 and
lp_0423 gene deletion mutants was performed as pre-
viously described [63] with several modifications. The
mutagenesis vectors were generated by a splicing by
overlap extension (SOE) procedure [64]. This procedure
was designed to expedite mutagenesis vector construc-
tion for L. plantarum using a single step, blunt-ended
cloning and positive selection for transformants based
on chloramphenicol resistance. PCR was used to amplify
approximately 1 kb of the 5’ and 3’ regions flanking the
genes targeted for deletion (for primer sequences see
Table 4). In addition, the loxP-cat-loxP region of
pNZ5319 was amplified using primers Ecl-loxR and
Pml-loxF (Table 4). For each mutagenesis vector, the
amplicons representing the corresponding 2 flanking
regions and the loxP-cat-loxP region were mixed in a
1:1:1 molar ratio and used as template in a second PCR
reaction with the 5’forward and 3’reverse flanking pri-
mers. These PCR reactions resulted in 3 kb amplicons
which were cloned into the integration vector pNZ5319
[63] after prior digestion of the vector with SwaI and
Ecl136II. Plasmids were transformed into competent
cells of E. coli JM109 by electroporation as recom-
mended by the manufacturer (Invitrogen). Plasmid DNA
was isolated from E. coli using Jetstar columns (Gen-
omed GmbH, Bad Oeynhausen, Germany) using the
manufacturer’s recommended protocol. DNA sequen-
cing (BaseClear, Leiden, The Netherlands) was per-
formed to confirm the integrity of the cloned genes.
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The resulting plasmids containing the complete gene
replacement cassettes were used for mutagenesis [63].
Statistical analysis
Linear mixed effect models using restricted maximum
likelihood (REML) were used to statistically compare
the mean cytokine values of IL-10, IL-12, and IL-10/IL-
12 produced in response to L. plantarum wild-type and
mutant cells. The effect of the donor on the response
variable was modeled as a random effect. The fixed
effects in the model were the strains (WCFS1 [wild
type], Δpts19ADCBR, Δlp_1953, ΔplnG, ΔplnEFI, and
ΔlamA ΔlamR) and the growth phase at the time of
harvest (exponential phase and stationary phase). Loga-
rithmic transformations of [IL-10], [IL-12] and [IL-10]/
[IL-12] yielded residuals that showed approximately nor-
mal distributions (data not shown) and, hence, were
used as the response variables in the fitting procedure.
Statistical analysis was performed using R http://www.r-
project.org, with the package “nlme” [65] for mixed
effect modeling. The donor random effect was modeled
as a constant offset relative to the average level of the
response variable ("model 1”), or alternatively, as a
donor-dependent offset plus a donor-dependent varia-
tion in the effect of the bacterial growth phase on the
response variable ("model 2”). Model 2 yielded better
fits for 2log([IL-10]) and 2log([IL-10]/[IL-12]) response
variables whereas, indications of a donor dependent
variation in growth phase effects were not found for the
2log([IL-12]) response, and hence model 1 was applied
for comparison of these cytokine amounts. The resulting
relative difference coefficients and t tests were calculated
from the fixed effects (mutation, growth phase, and their
interaction) using analysis of variance in R. The p-values
were adjusted for multiple hypothesis testing using the
correction procedures by Hochberg [66].
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Primer Sequencea
LF1953F 5’- TGCCGCATACCGAGTGAGTAG-3’
LF1953R 5’-CGAACGGTAGATTTAAATTGTTTATCAAAAAACACCGTTAATTTGCATC-3’
RF1953F 5’-GTACAGCCCGGGCATGAGCGTGGCCATTAGTTGACGAGAC-3’
RF1953R 5’-AACGCCATCGCACTGATGCATC-3’
Ecl-loxR 5’-AAACAATTTAAATCTACCGTTCG-3’
Pml-loxF 5’-CTCATGCCCGGGCTGTAC-3’
LF1953F2 5’-GCAACGGCTGTCAGTAACCTGCCTTC-3’
RF1953R2 5’-TCAAATCTCGAAGCGGTTCAAAACTG-3’
LF2647F 5’-GTACAGCCCGGGCATGAGGGTATTTAGCGAAATATACAGATTG-3’
LF2647R 5’-CTTTAGCCGTCTCATTAGTCG-3’
RF2651F 5’-GGATTACCAAAACGAACATGG-3’
RF2651R 5’-CGAACGGTAGATTTAAATTGTTTACTAGCCATTTTGTTTTTATCTCC-3’
LF2647R2 5’-TGACATGACTATCCTGACTTGC-3’
RF2651F2 5’-AACGTTCAACGGCAGATAAGCC-3’
LF423F 5’-AATTGATACATGTGGTTTCGAAAG-3’
LF423R 5’-CGAACGGTAGATTTAAATTGTTTCCAATGCATACTTGTACTCCC-3’
RF423F 5’-GTACAGCCCGGGCATGAG CGACTTGATCAATAGCTGAGGG-3’
RF423R 5’-TTGGTTGCCTTGATCGTGTAAG-3’
LF423F2 5’-CTTCAGTTATCGCTACAATCAACG-3’
RF423R2 5’-ACTAACGTACTTTGCACCACGG-3’
LF419F 5’-GTACAGCCCGGGCATGAGGACGAGTAATCATCCATTCTGA-3’
LF419R 5’-ATGAGTTTGCAATGGAGCTTAGG-3’
RF422F 5’-CAAAGACGTGCCGAATATAGCC-3’
RF422R 5’-CGAACGGTAGATTTAAATTGTTTAAACTGTAGCATAAATAATCCCC-3’
LF419R2 5’-GAGATAATTATTGTAAGACCGTC-3’
RF422F2 5’-CTAACGCATCAATAATCTTACTGG-3’
a Bold and underlined nucleotides signify overlapping ends with the Ecl-loxR and Pml-loxF primers.
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